Browsing by Author "Ishikawa T."

Sort by: Order: Results:

  • Hanada H.; Iwata T.; Kikuchi F.; Liu Q.; Matsumoto K.; Asari K.; Ishikawa T.; Ishihara Y.; Noda H.; Tsuruta S.; Petrova N.; Goossens S.; Harada Y.; Sasaki S.; Namiki N.; Kono Y.; Iwadate K.; Kameya O.; Jike T.; Shibata K.; Tamura Y.; Yahagi Y.; Masui W.; Tanaka K.; Maejima H.; Hong X.; Ping J.; Aili Y.; Ellingsen S.; Schlüter W. (2009)
    The Japanese lunar explorer SELENE (KAGUYA), which has been launched on Sep. 14th, 2007, utilizes VLBI observations in lunar gravimetry investigations. This can particularly improve the accuracy of the low degree gravitational ...
  • Hanada H.; Iwata T.; Liu Q.; Kikuchi F.; Matsumoto K.; Goossens S.; Harada Y.; Asari K.; Ishikawa T.; Ishihara Y.; Noda H.; Tsuruta S.; Petrova N.; Kawano N.; Sasaki S.; Sato K.; Namiki N.; Kono Y.; Iwadate K.; Kameya O.; Shibata K.; Tamura Y.; Kamata S.; Yahagi Y.; Masui W.; Tanaka K.; Maejima H.; Hong X.; Ping J.; Shi X.; Huang Q.; Aili Y.; Ellingsen S.; Schlüter W. (2010)
    The Japanese lunar explorer SELENE (Kaguya), which was launched on September 14th, 2007, was the target of VLBI observations over the period November 2007 to June 2009. These observations were made in order to improve the ...
  • Kikuchi F.; Liu Q.; Hanada H.; Kawano N.; Matsumoto K.; Iwata T.; Goossens S.; Asari K.; Ishihara Y.; Tsuruta S.; Ishikawa T.; Noda H.; Namiki N.; Petrova N.; Harada Y.; Ping J.; Sasaki S. (2009)
    Same beam very long baseline interferometry (VLBI) observations of the two subsatellites of SELENE (KAGUYA) are demonstrated for purpose of the precise gravimetry of the Moon. Same beam VLBI contributes a great deal to ...
  • Terai S.; Takami T.; Yamamoto N.; Fujisawa K.; Ishikawa T.; Urata Y.; Tanimoto H.; Iwamoto T.; Mizunaga Y.; Matsuda T.; Oono T.; Marumoto M.; Burganova G.; Quintanilha L.; Hidaka I.; Marumoto Y.; Saeki I.; Uchida K.; Yamasaki T.; Tani K.; Taura Y.; Fujii Y.; Nishina H.; Okita K.; Sakaida I. (2014)
    In 2003, we started autologous bone marrow cell infusion (ABMi) therapy for treating liver cirrhosis. ABMi therapy uses 400 mL of autologous bone marrow obtained under general anesthesia and infused mononuclear cells from ...

Search DSpace

Browse

My Account